Nucleotide of the liver that treat second kind medicaments be the champion

" Chinese medicine signs up for " dispatch is chronic on November 3 hepatitis B is a kind of potential progress sex deadly sex disease, show according to data of World Health Organization, second liver already became the mankind the 9th big cause of death, the liver cirrhosis of 90% above and liver cancer are caused by second liver. Our country is the tall hair area of world hepatitis B, also be market of the biggest pharmaceuticals of second liver cure, market dimensions exceeded the total of the United States, France, Germany, Italy and Spanish market 2005. Diagnose as second liver reach medication of rate rise ceaselessly, to 2010, liver of our country second treats medicaments vendibility to will grow one times. Current, the commonly used method that poison of second liver disease-resistant treats has cure of conditioning agent of interferon cure, nucleotide analogue cure, immunity and other treatment, among them nucleotide analogue cure has important place in clinical practice. Clinical the owner of nucleotide analogue curative that with Yu Yi liver treats wants to have: Rummy husband is decided, ester of A Defu Wei and favour replace Ka Wei. Nucleotide kind medicaments gradually 　 of of hold the market is right current and clinical commonly used 9 kinds of medicaments of virus of the liver that fight second undertake data analyses discovery, no matter be old controversy,ceaseless rummy husband is decided, just still appear on the market had be notted replace by the favour with hep people Ka Wei, for decide than the husband, all have on the market performance of beautiful, and their common feature all is nucleotide namely kind disease-resistant bane content. Content of before clinical rank 5 bane of second liver disease-resistant is husband of ester of A Defu Wei, rummy to decide, favour alcohol of the Wei that replace card, double-loop and Libaweilin, outside removing double-loop alcohol, the others all closes matter for nucleotide apperception. Libaweilin also is nucleotide apperception to close matter, but decide with rummy husband, the medicaments photograph that ester of A Defu Wei, favour replaces Ka Wei to wait to basically use virus of Yu Kangyi liver is compared, libaweilin defies bacterium table wider, weaker however to the specific aim of second liver virus. In taste the pressure that emerge in endlessly newly to fall, libaweilin is treating market evacuate from second liver virus gradually. Dimensions of market of content of bane of second liver disease-resistant appeared 2004 after small drop, 2005 and appeared 2006 relatively substantially growth, 2006 market dimensions relatively grew 60% 2005, on the base that increases so high, sampled 2007 the growth that data still has 25% than 2006. Since 2003, nucleotide kind disease-resistant bane content fights the sort in virus medicaments and share year after year to increase in second liver, only rummy husband decided 1 kind 2003, had increased 4 kinds 2007, portion also comes by 58.6% litres 85.5% 2007. Arrive when now, nucleotide kind disease-resistant bane content gradually hold the market, make the first selection that poison of second liver disease-resistant treats. The foreign enterprise takes actor, indigenous industry unwillings to lag behind company of production of content of bane of disease-resistant of liver of 　 second compares concentration, before was being ranked 2007 6 enterprise held the market share of 95.18% . Among them, the foreign enterprise has 3, 67% what take market of content of whole disease-resistant bane with medical amount, and held before the rank two position. Form the reason of this kind of phenomenon, because,be on one hand, thing of main bane of second liver disease-resistant all is brand name medicaments, the product is produced solely. Shi Ke of arrowroot orchid element produces rummy husband solely to decide, still have the market to behave additionally not the sale of the Asian area of the ester of A Defu Wei of common counterpoises. Shi Guibao has the favour exclusive production for Ka Wei to counterpoise. Beijing assist produce double-loop alcohol solely with the pharmaceutical factory, exclusive production replaces Nuo China pharmaceutical factory to be decided than the husband. As enter the market stage by stage for what decide than the husband, the force of foreign capital product will be increased further. In the meantime, because many manufacturer of domestic obtained ester of A Defu Wei,approve civil, the near future has the ester of A Defu Wei of a variety of brands to appear on the market, the market share certainly will of native land product also can increase. (the exercitation edits: Plum apricot)